Functional characterization of N-methyl-D-aspartic acid-gated channels in bone cells

Bone

Volumn 25, Issue 6, 1999, Pages 631-637

  Laketic Ljubojevic I ^a   Suva, L J ^a   Maathuis, F J M ^a   Sanders, D ^a   Skerry, T M ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Bone; Dizolcipine maleate (MK801); Glutamate receptors; Ion channels; N methyl D aspartic acid (NMDA) receptors; Osteoblasts

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; DIZOCILPINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; ION CHANNEL; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ARTICLE; BONE CELL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; OSTEOBLAST; SIGNAL TRANSDUCTION;

BINDING SITES; BONE AND BONES; CALCIUM; CELLS, CULTURED; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HUMANS; INTRACELLULAR FLUID; ION CHANNEL GATING; ION CHANNELS; KINETICS; MEMBRANE POTENTIALS; N-METHYLASPARTATE; OSTEOBLASTS; PATCH-CLAMP TECHNIQUES; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0345581359     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00224-0     Document Type: Article

References (38)

1. Behar V., Pines M., Nakamoto C., et al. The human PTH2 receptor Binding and signal transduction properties of the stably expressed recombinant receptor . Endocrinology. 137:1996;2748-2757.
2. Birch M.A., Genever P.G., Laketic I., et al. Glutamate receptor activation is necessary for bone formation in vitro. J Bone Miner Res. 12:1997;10. (abstr).
3. Bonewald L.F., Mundy G.R. Role of transforming growth factor beta in bone remodeling A review . Connect Tissue Res. 23:1989;201-208.
4. Chenu C., Serre C.M., Raynal C., Burt-Pichat B., Delmas P.D. Glutamate receptors are expressed by bone cells and are involved in bone resorption. Bone. 22:1998;295-299.
5. Collin-Osdoby P., Nickols G.A., Osdoby P. Bone cell function, regulation, and communication A role for nitric oxide . J Cell Biochem. 57:1995;399-408.
6. Davies J., Francis A.A., Jones A.W., Watkins J.C. 2-Amino-5-phosphonovalerate (2APV), a potent and selective antagonist of amino acid-induced and synaptic excitation. Neurosci Lett. 21:1981;77-81.
7. Dunlay R., Hruska K. PTH receptor coupling to phospholipase C is an alternate pathway of signal transduction in bone and kidney. Am J Physiol. 258:1990;F223-F231.
8. Etter A., Cully D.F., Liu K.K., et al. Picrotoxin blockade of invertebrate glutamate-gated chloride channels Subunit dependence and evidence for binding within the pore . J Neurochem. 72:1999;318-326.
9. Friedman J., Au W.Y., Raisz L.G. Responses of fetal rat bone to thyrocalcitonin in tissue culture. Endocrinology. 82:1968;149-156.
10. Genever P.G., Maxfield S.M., Kennovin G.D., et al. Evidence for a novel glutamate-mediated signalling pathway in keratinocytes. J Invest Dermatol. 112:1999;101-106.
11. Genever P.G., Wilkinson D.J.P., Patton A.J., et al. Expression of a functional NMDA-type glutamate receptor by bone marrow megakaryocytes. Blood. 93:1999;2876-2883.
12. Grabowski, P. S., Peet, N. M., and Skerry, T. M. Differential effects of the glutamate receptor antagonists phencyclidine and MK-801 on osteoclast absorption. Bone 22(Suppl.):26S; 1998 (abstr).
13. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 391:1981;85-100.
14. Heremans H., Billiau A., Cassiman J.J., Mulier J.C., deSomer P. In vitro cultivation of human tumor tissues. II. Morphological and virological characterization of three cell lines. Oncology. 35:1978;246-252.
15. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci. 17:1994;31-108.
16. Inagaki N., Kuromi H., Gonoi T., et al. Expression and role of ionotropic glutamate receptors in pancreatic islet cells. FASEB J. 9:1995;686-691.
17. 2+ block in NMDA receptor channels. J Neurosci. 16:1996;3549-3558.
18. Lacey D.L., Timms E., Tan H.L., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:1998;165-176.
19. Laube B., Kuhse J., Betz H. Evidence for a tetrameric structure of recombinant NMDA receptors. J Neurosci. 18:1998;2954-2961.
20. Lin C.L., Tzingounis A.V., Jin L., et al. Molecular cloning and expression of the rat EAAT4 glutamate transporter subtype. Brain Res Mol Brain Res. 63:1998;174-179.
21. Margulies J.E., Cohen R.W., Levine M.S., Watson J.B. Decreased GluR2(B) Receptor subunit messenger-RNA expression in cerebellar neurons at risk for degeneration. Dev Neurosci. 15:1993;110-120.
22. Mason D.J., Hillam R.A., Skerry T.M. Constitutive in vivo mRNA expression by osteocytes of beta-actin, osteocalcin, connexin-43, IGF-I, c-fos and c-jun, but not TNF-alpha nor tartrate-resistant acid phosphatase. J Bone Miner Res. 11:1996;350-357.
23. Monyer H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 12:1994;529-540.
24. Mori H., Masaki H., Yamakura T., Mishina M. Identification by mutagenesis of a Mg(2+)-block site of the NMDA receptor channel. Nature. 358:1992;673-675.
25. Muller G., Endermann U., Bresink I., Turski L. Glutamate in neurodegenerative disorders Phenotype resulting from decreased expression of AMPA receptor GluR-B subunit mRNA in rats . Seeburg P.H., Bresink I., Turski L. Excitatory Amino Acids. 1998;109-126 Springer, Berlin, Germany.
26. Mundy G.R., Boyce B., Hughes D., et al. The effects of cytokines and growth factors on osteoblastic cells. Bone. 17:(Suppl.):1995;71S-75S.
27. Patton A.J., Genever P.G., Birch M.A., Suva L.J., Skerry T.M. Expression of an N-methyl-D-aspartate-Type receptor by human and rat osteoblasts and osteoclasts suggests a novel glutamate signalling pathway in bone. Bone. 22:1998;645-649.
28. Peet, N. M., Grabowski, P. S., Laketic-Ljubojevic, I., and Skerry, T. M. The glutamate receptor antagonist Mk801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation. FASEB J. In press.
29. Rosenmund C., Stern-Bach Y., Stevens C.F. The tetrameric structure of a glutamate receptor channel. Science. 280:1998;1596-1599.
30. Said S.I., Berisha H.I., Pakbaz H. Excitotoxicity in the lung N-methyl-D-aspartate-induced, nitric oxide-dependent, pulmonary edema is attenuated by vasoactive intestinal peptide and by inhibitors of poly(ADP-ribose) polymerase . Proc Natl Acad Sci USA. 93:1996;4688-4692.
31. Schirrmacher K., Bingmann D. Effects of vitamin D-3, 17beta-estradiol, vasoactive intestinal peptide, and glutamate on electric coupling between rat osteoblast-like cells in vitro. Bone. 23:1998;521-526.
32. Semenov E.P., Pak W.L. Diversification of Drosophila chloride channel gene by multiple posttranscriptional mRNA modifications. J Neurochem. 72:1999;66-72.
33. Skerry, T. M., Genever, P. G., Patton, A. J., et al. Glutamate receptors in bone cells suggest a paracrine role for excitatory amino acids in regulation of the skeleton? J Bone Miner Res 11(Suppl.):S141; 1996 (abstr).
34. Sun L.X., Margolis F.L., Shipley M.T., Lidow M.S. Identification of a long variant of mRNA encoding the NR3 subunit of the NMDA receptor Its regional distribution and developmental expression in the rat brain . Fed Eur Bone Soc Lett. 441:1998;392-396.
35. Vilien M., Wolf H. The specificity of the microcytotoxicity assay for cell-mediated immunity in human bladder cancer. J Urol. 119:1978;338-342.
36. Yasuda H., Shima N., Nakagawa N., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA. 95:1998;3597-3602.
37. Yellowley C.E., Hancox J.C., Skerry T.M., Levi A.J. Whole-cell membrane currents from human osteoblast-like cells. Calcif Tissue Int. 62:1998;122-132.
38. Ypey D.L., Weidema A.F., Hold K.M., et al. Voltage, calcium, and stretch activated ionic channels and intracellular calcium in bone cells. J Bone Miner Res. 7:(Suppl. 2):1992;S377-S387.